AP
TNDM icon

Appleton Partners’s Tandem Diabetes Care TNDM Stock Holding History

Appleton Partners’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,080
Closed -$242K – 308
2022
Q1 		$242K Hold
2,080
– – 0.02% 284
2021
Q4 		$313K Sell
2,080
-145
-7% -$19.6K 0.02% 259
2021
Q3 		$266K Hold
2,225
– – 0.02% 261
2021
Q2 		$217K Buy
+2,225
New +$198K 0.02% 281
2021
Q1 		– Sell
-2,310
Closed -$221K – 284
2020
Q4 		$221K Hold
2,310
– – 0.02% 263
2020
Q3 		$262K Sell
2,310
-200
-8% -$21K 0.03% 238
2020
Q2 		$248K Buy
+2,510
New +$200K 0.03% 231
2017
Q4 		– Sell
-2,670
Closed -$19K – 260
2017
Q3 		$19K Buy
+2,670
New +$16.9K ﹤0.01% 237

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Appleton Partners's TNDM Position: Q2 2022 in Review

Appleton Partners sold out of Tandem Diabetes Care (TNDM) in Q2 2022, closing a stake of 2,080 shares — an estimated $242K sold.

Appleton Partners first reported a position in TNDM in Q3 2017 and held it in 8 quarters. The position peaked at $313K in Q4 2021. 330 funds tracked by Wall St. Rank hold TNDM as of Q2 2022.

  • Appleton Partners reported no remaining Tandem Diabetes Care position as of Q2 2022 after selling out during the quarter.
  • Appleton Partners sold 2,080 Tandem Diabetes Care shares in Q2 2022, an estimated $242K.
  • Appleton Partners first reported a position in Tandem Diabetes Care in Q3 2017 and held it in 8 quarters.
  • Appleton Partners's Tandem Diabetes Care position peaked at $313K in Q4 2021.
  • 330 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2022.

Based on Appleton Partners's 13F filing for Q2 2022, filed 8 Jul 2022.